Results 21 to 30 of about 12,136 (324)
BMC Anesthesiology, 2023 Background Sugammadex has been reported to lower the incidence of postoperative residual neuromuscular blockade. Despite the advantages, until recently the effects of sugammadex on postoperative pulmonary complications (PPCs) were controversial.
Hong-Mei Liu +3 more
semanticscholar +1 more source
Sugammadex in the neonatal patient☆ [PDF]
Colombian Journal of Anesthesiology, 2013 Abstract Introduction The inclusion of drugs that effectively reverse the neuromuscular junction blockade enhances the profile of drugs used for relaxation of the neuromuscular junction; better yet if these agents are free from any clinically important adverse effects and amenable to use in neonates.
González Cárdenas, Víctor Hugo +1 more
openaire +3 more sources
Scientific Reports, 2022 Sugammadex has been approved for reversal of neuromuscular blockade by vecuronium and rocuronium in adults undergoing surgery. Although widely used in the operating room, sugammadex has not been investigated in the intensive care unit setting. This study
Răzvan Bologheanu +5 more
doaj +1 more source
Advantages and pitfalls of clinical application of sugammadex [PDF]
Anesthesia and Pain Medicine, 2020 Sugammadex, a modified γ-cyclodextrin, is one of the drugs focused on in the anesthetic field because it provides rapid and complete reversal from neuromuscular blockade (NMB) by encapsulating rocuronium.
Hyung Young Lee, Ki Tae Jung
doaj +1 more source
Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex -a case report- [PDF]
Korean Journal of Anesthesiology, 2019 Background Sugammadex is a reversal agent for non-depolarizing neuromuscular blockers and widely used worldwide on account of its rapid and effective reversal from neuromuscular blockade, despite its advantages, multiple cases of sugammadex-induced ...
Gunn Hee Kim +6 more
doaj +1 more source
Healthcare, 2023 Sugammadex has several pharmacological advantages over neostigmine, including faster reversal of neuromuscular blockade and fewer adverse effects. However, the economic impact of sugammadex remains controversial due to the considerable heterogeneity of ...
Winnie Lan +9 more
semanticscholar +1 more source
Clinical and Translational Science, 2023 Sugammadex, a selective antagonist of steroidal non‐depolarizing neuromuscular blocking agents, has been used in children in limited circumstances. However, neither pharmacokinetics (PKs) nor recovery profile of sugammadex for intense neuromuscular ...
Sang‐Hwan Ji +8 more
doaj +1 more source
Rocuronium-sugammadex use for electroconvulsive therapy in a hemodialysis patient: a case report
JA Clinical Reports, 2016 Background Recently, rocuronium with subsequent use of sugammadex was proposed for electroconvulsive therapy (ECT) as an alternative to succinylcholine.
Shigeaki Kurita +5 more
doaj +1 more source
Cardiac arrest following sugammadex administration
Anaesthesia Reports, 2023 A 68‐year‐old man underwent elective surgical repair of an abdominal wall hernia under general anaesthesia. The operation required muscle relaxation, for which we used rocuronium.
A. V. Pereira +3 more
semanticscholar +1 more source
Profile of sugammadex for reversal of neuromuscular blockade in the elderly: Current perspectives [PDF]
, 2017 The number of elderly patients is increasing worldwide. This will have a significant impact on the practice of anesthesia in future decades. Anesthesiologists must provide care for an increasing number of elderly patients, who have an elevated risk of ...
Bertoncello, Francesco +2 more
core +1 more source